Impaired wound healing is one of the most important complications of diabetes mellitus. Though infection is not one of the pathogenic triad for development of diabetic foot ulcers, it is an extremely important cause of morbidity and hospitalization, amputation, and impaired healing based on clinical and other evidence from over the world. Approximately 3% to 4% of individuals with diabetes currently have foot ulcers or deep infections. [1] [2] [3] A multicenter survey in China showed that in patients with diabetic foot disease, 67.9% develop foot infections. 4 In the Middle East the prevalence of infection in diabetic patients was reported to be greater than 40%. 5, 6 There have been reports from India that are alarming. It is also thought that this problem is yet undefined in some well-populated parts of the world.
Microbial Etiology of Diabetic Foot Infection
Diabetic patients are at increased risk of severe skin and bone infections. Analysis of epidemiology and microbial pathogenicity shows that, gram-positive cocci, particularly Staphylococcus aureus, are the most important pathogens in diabetic foot infections. Gram-negative bacilli account for about 20% to 30% of the organisms. Although more than half of the infections are reportedly monomicrobial, polymicrobial infections are becoming common. [7] [8] [9] Initial bacterial adherence is a result of hydrophobicity, ion exchanges, and specific binding of bacterial adhesion molecules to cellular receptors. Moreover, staphylococci secrete polysaccharides, which form a biofilm together with multilayer cell clusters, which are resistant to distinct immunoeffectors and have a decreased susceptibility to antibiotics in vivo. Gram-negative bacterials exert their pathological effects mainly by secreting endotoxins. It is important to note that there growing tendency to report fungal infections in the diabetic foot as well. 10, 11 Conventionally, regimens for severe and chronic infections are broad spectrum and often administered intravenously to obtain high drug concentrations immediately. But the increasing multidrug-resistant and fungal infections effectively decrease the efficiency of antibiotic therapy. However, the total microbiological aspects remind one of the importance of an integrated management, including assessment, appropriate wound care, fluid management, metabolic control, surgical and antibiotic intervention, and recently developed concepts of therapy such as topical negative pressure. For all these reasons, this issue of IJLEW has a focus on the topic of the infected diabetic foot. The topic is wide enough to deem more space than one issue in IJLEW but a little at a time consistently will serve to draw more attention to this problem.
Risk Factors of Diabetic Foot Infection
The evidence for the risk factors of diabetic foot have been discussed and are accepted. Theoretically, evaluations on the biomechanical, ischemia, neurophathy, vascular disease, and metabolic effects of diabetes are components to the overall severity of the infection, as well as the risk of diabetic foot infection. Duration of diabetes mellitus, poor glycemia control, previous extremity ulcer, neuropathy, peripheral vascular disease, foot biomechanics, age, and perhaps gender are regarded as the risk factors. 12, 13 Some suggested that independent risk factors for developing osteomyelitis are deep, recurrent, and multiple wounds. 14 It was reported that the risk factors of diabetic foot infections were dependent on the type of diabetes mellitus. There is also evidence that smoking is a risk factor. In some areas, especially south Asia and Africa, walking barefoot was suggested a risk factor for foot ulcers, though the precise influence on diabetic foot infections still needs further study. 15, 16 Although we have heard about risk factors-related diabetic foot infections, arguments continue on some of the more key aspects. Some researchers believe microbial load to be a significant factor though previous studies on the microbiology of diabetic foot infections have not provided sufficient evidence that permit the determination of the important microbiological parameters. Another is the issue of hyperglycemia metabolic profile. Many studies have revealed that increased advanced glycation end-products formation has potentially detrimental effects on impaired healing and related inflammation with diabetes, 17 but these remain to be confirmed from well-designed studies.
Diagnosis of Diabetic Foot Infection
Diabetic foot infections require attention to local (foot) and systemic (metabolic) issues and coordinated management. Wound infections are diagnosed clinically on the basis of local (and occasionally systemic) signs and symptoms of inflammation, and laboratory (including microbiological) investigations.
Evaluating the wound and infection is the basis of diagnostic procedure. A wound should be defined for its location and description. Infection should be diagnosed clinically for the presence of purulent secretions or the cardinal manifestations of inflammation (redness, warmth, swelling or induration, pain, or tenderness). This method permits dichotomous assessment of diabetic foot infection. However, to determine the overall severity of the infection and to formulate a management plan, the severity of infections must be evaluated and determined and accordingly the appropriate approach to treatment can be selected. Discrimination between the neuropathic and neuroischemic foot could have a major influence on treatment.
The Wagner and Texas systems 18 for classifying diabetic foot wounds have been widely used for decades, but they are of limited use for diagnosing infection, mainly because they locate all infections within a single grade. Sadly, a lack of consensus on wound definitions and infection classification systems exists, which limits an acceptable diagnosis of infection. The International Consensus on the Diabetic Foot published a preliminary progress report on a diabetic foot ulcer classification system for research purposes. 19 The key elements are summarized by the acronym PEDIS (perfusion, extent/size, depth/tissue loss, infection, and sensation). The infection category includes grade 1 (no infection), grade 2 (involvement of skin and subcutaneous tissue only), grade 3 (extensive cellulitis or deeper infection), and grade 4 (presence of a systemic inflammatory response syndrome). This classification needs to be proved satisfactory in clinical circumstances.
Laboratory tests play their roles in the detection of infection, mainly including the microbial etiology of the infection, the biology or pathogenesis of the wound, any contribution of altered foot biomechanics to the cause of the wound, any contribution of vascular disease, and the presence of any systemic consequences of infection. Among these, microbial etiology may be determined by examining biopsies or purulent secretions. It is argued that wound edge biopsy yielding more than 10 5 counts per gram of tissue constitutes a definition. Many argue against this method because of its lack of universal applicability especially on unbroken diabetic foot skin and have sought to analyze carefully collected samples of wound exudate and published data on the presence of pro-inflammatory and anti-inflammatory markers as well as enzymes that cause tissue to breakdown faster than it repairs leaving a net imbalance of the extracellular matrix synthesis. 20, 21 
Management for Diabetic Foot Infection
Traditionally, mild to moderate diabetic foot infections often respond favorably to local wound care, offloading, and antibiotic therapy. Although the initial therapy is usually empirical it should be based on the severity of the infection and on any available microbiological data. Patients who have chronic wounds or who have recently received antibiotic therapy may also be infected with gram-negative rods and/or fungi, and those with foot ischemia or gangrene may have obligate anaerobic pathogens. Actually, completely conservative measures are not likely to be very effective in controlling diabetic foot infections. When conservative measures fail or when faced with limb or life-threatening infection, surgical intervention, whether it be incision and drainage or possible amputation, is warranted.
Many infections require surgical procedures that range from drainage and excision of infected and necrotic tissues to revascularization of the lower extremity and reconstruction of soft-tissue defects or mechanical misalignments. When determining the need for surgery, timely and aggressive surgical debridement, including limited resections or amputations, may reduce the need for major amputations. The surgeon must determine the adequacy of the blood supply to the remaining viable tissues, consider common operative pitfalls (eg, infection spreading among foot compartments, to the deep plantar space, or along the tendon sheaths), and formulate a strategy for eventual soft-tissue cover (eg, primary closure, delayed primary closure, secondary intention, or tissue transfer). The surgical approach should optimize the likelihood for healing and should attempt to preserve the integrity of the walking surface of the foot. In most instances, the surgeon should continue to observe the patient until the infection is under control and the wound is healing. Despite the numerous research efforts, there is a lack of unanimity on the techniques of management and indeed the optimal timing of surgery. Some new techniques, for example, topical negative pressure therapy, are gaining wider acceptability. There are clinical circumstances situations when such therapy is inappropriate, for example, when tissue perfusion is critically impaired. 22, 23 
